Cyclopentolate: Clinical Trials

10 trials of Cyclopentolate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 1 withdrawn. 5 Phase 4, 2 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 3, Completed 2
Not applicable2Completed 2
Phase 11Withdrawn 1
Phase 31Completed 1

Follow Cyclopentolate: new trials by email Literature Review of Cyclopentolate trials Research Report on Cyclopentolate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cycloplegic Refraction in Pediatric Patients With Esotropia
Cyclopentolate, Tropicamide - Cycloplegia, Refractive Errors
Phase 4UnknownIslamic Hospital, Jordan1002023-09-012023-10-11
Cycloplegic Refraction Among Children
Cyclopentolate, Tropicamide - Cycloplegia
Phase 4CompletedIslamic Hospital, Jordan552022-03-012022-07-05
Mydriatic Drops After Combined Surgery
Cyclopentolate Hydrochloride 1.0% eye drops - Posterior Synechiae of Iris
Not applicableCompletedRabin Medical Center602020-11-102022-11-14
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
Atropine sulfate and epinephrine, Topical cyclopentolate and phenylephrine - Cataract, Mydriasis
Phase 4UnknownDar El Oyoun Hospital402018-09-282018-10-09
Evaluation of a Protocol of Pupil Dilation Before Laser-assisted Cataract Surgery
cyclopentolate 0.5% eye drops - Cataract Surgery
CompletedCHU de Reims602018-06-012024-08-22
Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
PACK-CXL, Cefazolin in combination with either tobramycin or gentamicin, Cycloplegic agents (cyclopentolate 1% eye drops) - Keratitis; Infectious Disease (Manifestation)
Phase 3CompletedUniversity Hospital, Geneva352016-03-012020-10-20
A New More Efficient Cycloplegia Scheme
Cyclopentolate, Cyclopentolate+tropicamide+phenylephrine - Refractive Errors
Phase 4UnknownPontificia Universidad Catolica de Chile302014-05-012014-06-27
Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study
0.5% cyclopentolate and 2.5% phenylephrine, 0.5% tropicamide + 0.5% phenylephrine, 0.5% tropicamide + 0.5% phenylephrine with a cotton wick - Retinopathy of Prematurity
Phase 4CompletedUniversity of the Philippines602011-09-302021-04-09
Study on Effective Mydriasis in Premature Infants
1% phenylephrine and 0.2% cyclopentolate - Retinopathy of Prematurity (ROP)
Not applicableCompletedGeorgetown University152007-03-012010-01-22
Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?
cyclopentolate - Refractive Error - Myopia
Phase 1WithdrawnKK Women's and Children's Hospital1802005-12-012011-10-05

Conditions studied

Refractive Errors (3)  ·  Retinopathy of Prematurity (2)  ·  Cataract (1)  ·  Communicable Diseases (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Esotropia (1)  ·  Keratitis (1)  ·  Mydriasis (1)  ·  Premature Birth (1)  ·  Vision Disorders (1)

Sponsors

Islamic Hospital, Jordan (2)  ·  CHU de Reims (1)  ·  Dar El Oyoun Hospital (1)  ·  Georgetown University (1)  ·  KK Women's and Children's Hospital (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  Rabin Medical Center (1)  ·  University Hospital, Geneva (1)  ·  University of the Philippines (1)

Countries

Jordan (2)  ·  Chile (1)  ·  Egypt (1)  ·  France (1)  ·  Israel (1)  ·  Qatar (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Cristian Salgado (1)  ·  Farhad Hafezi, MD, PhD (1)  ·  Monisha Bahri, MD (1)  ·  Quah Boon Long (1)  ·  Rami Al-Omari, MD (1)  ·  Roland Joseph D Tan, MD (1)  ·  Wejdan Al-Thawabieh, MD (1)

Results publications

PMID 32557558, PMID 34996516